We use cookies to analyze site traffic and improve your experience.
By accepting, you consent to the use of analytics cookies.

PATH:NYSEUiPath, Inc. Analysis

Data as of 2026-04-23 - not real-time

$10.18

Latest Price

7/10Risk

Risk Level: Medium

Executive Summary

UiPath’s stock is trading at $10.18, well below its 20‑day ($10.60), 50‑day ($11.03) and 200‑day ($13.16) simple moving averages, signaling a bearish technical backdrop, while the RSI sits at 42 and the MACD histogram has turned positive, hinting at a tentative bullish momentum. Volume is on the rise, but 30‑day volatility is extremely high at over 60% and beta exceeds 1.3, underscoring substantial price swing risk. On the fundamentals side, the company posted $1.61 B in revenue with 13.6% YoY growth, gross margins above 80%, and a profit margin of 17.5%, supported by a strong cash pile of $1.47 B and minimal debt. A discounted cash‑flow model values PATH at roughly $24.3, implying more than 30% upside, and the forward PE of 11.4 is well under the industry average of 37.
The recent strategic alliance with Deloitte to launch an Agentic ERP solution leverages UiPath’s Maestro and Agent Builder platforms, positioning the firm at the forefront of AI‑driven automation. Analyst consensus remains a “hold” with median price targets near $13.4, while market sentiment is in an “Extreme Greed” phase, suggesting investors are already pricing in optimism. Combined, the undervalued valuation, solid profitability, and growth‑oriented news create a compelling case for medium‑ to long‑term investors, albeit tempered by short‑term technical weakness and high volatility.

Market Outlook

Short Term

< 1 year
Neutral
Model confidence: 6/10

Key Factors

  • Price below key moving averages indicating bearish bias
  • High short‑term volatility and beta
  • Support level around $9.28 providing downside cushion

Medium Term

1–3 years
Positive
Model confidence: 8/10

Key Factors

  • 13.6% revenue growth and strong margin profile
  • Strategic Deloitte partnership expanding AI‑ERP footprint
  • DCF‑derived fair value suggesting >30% upside

Long Term

> 3 years
Positive
Model confidence: 9/10

Key Factors

  • Robust cash position and minimal debt enabling continued investment
  • Leadership in the rapidly expanding RPA and agentic AI market
  • Valuation gap relative to peers and long‑term growth trajectory

Key Metrics & Analysis

Financial Health

Revenue Growth13.60%
Profit Margin17.53%
P/E Ratio19.6
ROE14.37%
ROA1.26%
Debt/Equity3.90
P/B Ratio2.6
Op. Cash Flow$371.2M
Free Cash Flow$473.6M
Industry P/E37.0

Technical Analysis

TrendBearish
RSI42.3
Support$9.28
Resistance$11.42
MA 20$10.60
MA 50$11.03
MA 200$13.16
MACDBullish
VolumeIncreasing
Fear & Greed Index86.07

Valuation

Fair Value$24.26
Target Price$13.81
Upside/Downside35.61%
GradeUndervalued
TypeGrowth

Risk Assessment

Beta1.36
Volatility61.56%
Sector RiskMedium
Reg. RiskMedium
Geo RiskLow
Currency RiskLow
Liquidity RiskLow

This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.